person
as of 2026-07-01Berthold Langguth, MD, PhD
at a glance
Roles: Study Chair, Author
KOL signal score 4
1 publications · 1 high-value
Cross-drug reach: 1 competitor drugs
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
University of Regensburg
Roles
Study Chair, Author
KOL signal
4
Publications
1 (1 high-value)
Trial investigator
no
Publishes on
1 drugs
Trials led
1
rTMS Add on Value for Amelioration of Negative Symptoms of Schizophrenia
NCT04318977—Active Not Recruiting
Publications & congress
1
Identifying differential predictors for treatment response to amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia: Results of the COMBINE-study.
Schizophrenia research · 2024 · high-value
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
publishes on
drug